Skip to content

Clinical trials

Respiratory Distress Syndrome trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Country / region: Japan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20202
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Enrolling by invitation2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Healios K.K.1
Hiroshima University1
Japanese Society for Early Mobilization1
KK Women's and Children's Hospital1
St. Justine's Hospital1
Toray Industries, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome8
COVID-193
Acute Lung Injury2
Severe Acute Respiratory Syndrome2
Coronavirus Infections1
Infections1
Influenza, Human1
Lung Diseases1
Pneumonia1
Pneumonia, Viral1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.